Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Pharmacological Research|January 26, 2016
Cisplatin resistance and opportunities for precision medicineLauren AmableOncology Reports|June 14, 2014
Gli1 contributes to cellular resistance to cisplatin through altered cellular accumulation of the drugLauren Amable, Jason Fain, Elaine Gavin, et al.The Journal of Biological Chemistry|September 17, 2011
Disruption of serine/threonine protein phosphatase 5 (PP5:PPP5c) in mice reveals a novel role for PP5 in the regulation of ultraviolet light-induced phosphorylation of serine/threonine protein kinase Chk1 (CHEK1)Lauren Amable, Nina Grankvist, Jason W Largen, et al.International Journal of Oncology|December 25, 2013
GLI1 upregulates C-JUN through a specific 130-kDa isoformLauren Amable, Elaine Gavin, Kenji Kudo, et al.The Biochemical Journal|August 23, 2003
Family 18 chitinase-oligosaccharide substrate interaction: subsite preference and anomer selectivity of Serratia marcescens chitinase ANathan N Aronson, Brian A Halloran, Mikhail F Alexyev, et al.Plos One|August 10, 2012
Calcineurin regulates homologous desensitization of natriuretic peptide receptor-A and inhibits ANP-induced testosterone production in MA-10 cellsMichelle B Henesy, Andrea L Britain, Bing Zhu, et al.Biochimica Et Biophysica Acta|February 19, 2008
Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancerTeresa Golden, Ileana V Aragon, Beth Rutland, et al.The Journal of Pharmacology and Experimental Therapeutics|July 14, 2009
Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitorsMark R Swingle, Lauren Amable, Brian G Lawhorn, et al.Journal of the American Chemical Society|December 21, 2006
Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibitionBrian G Lawhorn, Sobhana B Boga, Scott E Wolkenberg, et al.Nature Communications|November 23, 2017
Cisplatin is retained in the cochlea indefinitely following chemotherapyAndrew M Breglio, Aaron E Rusheen, Eric D Shide, et al.Pageof 2